There isn't a single burning, insurmountable issue because of which workers at Maruti's Manesar plant have struck work thrice in the last five months . Sruthijith KK & Chanchal Pal Chauhan report from Manesar that at its core lie accumulated grievances and resentment, and events are adding fuel to the fire A day after workers at Maruti Suzuki's Manesar facility went on strike in June, 55-year-old MM Singh, the company's head...
More »SEARCH RESULT
PM Manmohan Singh calls for review of RTI Act
-The Economic Times Prime Minister Manmohan Singh has called for a review of the Right to Information (RTI) Act, one of the UPA's trophy legislations, potentially exposing the government to a fresh stand-off with civil society. Addressing a two-day annual convention of the Central Information Commission here, Singh said the transparency law should not adversely affect deliberative processes in the government and discourage honest, well-meaning public servants from voicing their views. He...
More »The Inconvenient Truth Of Soni Sori by Shoma Chaudhury
Why were two tribals and the Essar group framed by the Chhattisgarh police? Why are Soni Sori and Linga Kodopi being systematically silenced? This chilling story of one family reveals more about India's Naxal crisis than any official document can. AS I sit to write this, at 12.20 pm on 4 October 2011, an SMS pops up on my phone: “Soni Sori has been arrested by the Delhi Crime Branch.” The...
More »Can you have Nilekani without UID? by Subir Roy
Both Nandan Nilekani and his well-wishers are today, two years after he set out on his unique identification (UID) journey, wiser if not a more disillusioned lot. Right at the outset he had acknowledged concerns over privacy issues, saying, “India does not really have a privacy law. So all this will act as an impetus to define the privacy framework for Indians.” That gaping hole is still staring us in...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »